GlassScriptPhysician profile
David A Bliklen
NPI 1548223936
$2,067.10
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,053 · 2020: $14.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $365.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $239.25 | 2019 | |
| Biogen, INC. | $193.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $159.36 | 2019 | |
| Genzyme Corporation | $137.27 | 2019 | |
| Livanova USA, INC. | $126.68 | 2019-2020 | |
| Genentech USA, INC. | $85.28 | 2019 | |
| Sunovion Pharmaceuticals INC. | $84.03 | 2019 | |
| Emd Serono, INC. | $80.70 | 2019 | |
| Acadia Pharmaceuticals INC | $69.36 | 2019 | |
| Amneal Pharmaceuticals LLC | $54.66 | 2019 | |
| Supernus Pharmaceuticals, INC. | $54.45 | 2019 | |
| Acorda Therapeutics, INC | $52.94 | 2019 | |
| Allergan, INC. | $44.19 | 2019 | |
| Zyla Life Sciences, INC. | $43.80 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $39.98 | 2019 | |
| Medtronic USA, INC. | $36.06 | 2019 | |
| Mallinckrodt Enterprises LLC | $34.74 | 2019 | |
| Amgen INC. | $32.78 | 2019 | |
| Alexion Pharmaceuticals, INC. | $28.39 | 2019 | |
| Neurocrine Biosciences, INC. | $25.28 | 2019 | |
| Shire North American Group INC | $22.19 | 2019 | |
| Pfizer INC. | $16.11 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.22 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.07 | 2019 | |
| Mdd US Operations, LLC | $12.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bliklen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.